Tag: Pharmaceutical Regulation
-
Paediatric ADHD Meds: Why Australia Urges Child-Friendly Formulations to Prevent Poisonings
Why Paediatric ADHD Formulations Matter Concerns around ADHD medications have surged as data reveals a troubling rise in pediatric poisonings linked to adult ADHD tablets being split for children. In the last decade, cases have quadrupled, drawing attention to a gap between available medicines and the specific needs of younger patients. Experts say that withholding…
-
UK Crime Gangs Turn to Branded Weight-Loss Drugs, Blurring Lines With Legitimate Medicine
Growing Threat: Criminals Are Manufacturing Branded Weight-Loss Drugs UK authorities have raised alarms that organised crime gangs are now producing their own branded weight-loss drugs. The trend, described by the Medicines and Healthcare products Regulatory Agency (MHRA) as a significant threat, involves illicit labs creating pills and liquids that look like legitimate medicines and are…
-
FDA Warns of Prasozin Hydrochloride Recall Over Potential Carcinogen in Blood Pressure Medication
Overview: FDA Issues Recall for Prazosin Hydrochloride The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of prazosin hydrochloride, a medication used to treat high blood pressure and related conditions. The action comes after concerns that the drug product may contain a chemical suspected of causing cancer. The recall affects more than…
-
WHO Highlights Contaminated Cough Syrups in India After Madhya Pradesh Child Deaths
Global health alert ties Indian cough syrups to child fatalities The World Health Organization (WHO) has identified three cough syrups manufactured in India as potentially dangerous, following a tragic wave of child deaths in Madhya Pradesh. The agency urged health authorities to report any detections of these specific syrups in their countries. The development marks…
-
India Faces Yet Another Cough Syrup Poisoning as Diethylene Glycol Contaminations Resurface
Overview: Poison in a Common Household Medicine In another deadly chapter of a long-running public health concern, India has reported multiple cough syrup contaminations linked to diethylene glycol, a toxic industrial solvent. At least 19 children have died after consuming medicines marketed as relief from cough and fever. The outbreak underlines a pattern that has…
-
India Cough Syrup Poisonings Reignite Health Crisis
New Wave of Cough Syrup Contamination in India Sparks Alarm More Indian cough syrups are under scrutiny as authorities confront a deadly pattern that has claimed dozens of young lives over decades. The latest wave centers on diethylene glycol, a toxic industrial solvent found in batches of cough syrup sold in India. The revelations have…
-
India’s Cough Syrup Contamination: A Recurrent Public Health Crisis
Overview: A Tragic Pattern Repeats Another deadly episode in India’s ongoing struggle with pharmaceutical safety has claimed more young lives. At least 19 children died after consuming cough syrup contaminated with diethylene glycol, a toxic industrial solvent. The tainted product, marketed as Coldrif, was linked to fatalities in multiple regions, triggering arrests, factory shutdowns, and…
-
Toxic Cough Syrup Case: Arrest of Pharma Boss Sparks MP Accountability Debate
Overview of the Case A seven-member Madhya Pradesh (MP) team arrested G Ranganathan, the Chennai-based owner of Sresan Pharmaceuticals, amid investigations into the toxic Coldrif cough syrup linked to 21 deaths. Local authorities have sealed Ranganathan’s 2,000-square-foot manufacturing unit on the Chennai-Bengaluru highway and cleared his registered office in Kodambakkam as part of a widening…